Cedar, a NYC-based patient engagement and financial technology platform, received an investment from Concord Health Partners, a healthcare focused investment firm as part of its Series C funding.
The amount of the deal was not disclosed.
Concord’s participation in Cedar’s Series C funding will enable the company to accelerate investment in core product development.
Led by Florian Otto, CEO and co-founder, Cedar facilitates patient-centric financial engagement across the entire care journey through personalized outreach and a seamless user experience. Over the past year, it has realized substantial growth through innovative institutional collaborations, including a partnership with Novant Health that was announced on June 22.
As was announced on June 22, Cedar’s Series C funding round was led by Andreesen Horowitz. Other participants included JP Morgan, Kaiser Permanente and individual angel investors including Jerod Mayo, linebacker coach for the New England Patriots and Jeff Vacirca, MD, FACP and CEO of New York Cancer & Blood Specialists, as well as current investors including Kinnevik, Thrive Capital, Lakestar and Founders Fund.